PCI or CABG in coronary artery disease?

The Lancet

Volumn 373, Issue 9670, 2009, Pages 1150-1152

  Taggart, David P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; STROKE; SURVIVAL RATE;

EID: 63349088614     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60574-2     Document Type: Note

References (21)

1. Hlatky M.A., Boothroyd D.B., Bravata D.M., et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet (2009) 10.1016/S0140-6736(09)60552-3 published online March 20.
2. Serruys P.W., Morice M.C., Kappetein A.P., et al., for the SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
3. Taggart D.P. Thomas B Ferguson Lecture: coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 82 (2006) 1966-1975
4. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
5. Brener S.J., Lytle B.W., Casserly I.P., Schneider J.P., Topol E.J., and Lauer M.S. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109 (2004) 2290-2295
6. Hannan E.L., Racz M.J., Walford G., et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352 (2005) 2174-2183
7. Malenka D.J., Leavitt B.J., Hearne M.J., et al., for the Northern New England Cardiovascular Disease Study Group. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation 112 suppl 9 (2005) I371-I376
8. Smith P.K., Califf R.M., Tuttle R.H., et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 82 (2006) 1420-1428
9. Bair T.L., Muhlestein J.B., May H.T., et al. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry. Circulation 116 suppl 11 (2007) I226-I231
10. Hannan E.L., Wu C., Walford G., et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358 (2008) 331-341
11. Boden W.E., O'Rourke R.A., Teo K.K., et al., for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
12. Loop F.D., Lytle B.W., Cosgrove D.M., et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314 (1986) 1-6
13. Lytle B.W., Blackstone E.H., Sabik J.F., Houghtaling P., Loop F.D., and Cosgrove D.M. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 78 (2004) 2005-2012
14. Taggart D.P., D'Amico R., and Altman D.G. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358 (2001) 870-875
15. Kastrati A., Mehilli J., Pache J., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 35 (2007) 1030-1039
16. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
17. Hoffman S.N., TenBrook J.A., Wolf M.P., Pauker S.G., Salem D.N., and Wong J.B. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
18. Bravata D.M., Gienger A.L., McDonald K.M., et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 147 (2007) 703-716
19. Niles N.W., McGrath P.D., Malenka D., et al., for the Northern New England Cardiovascular Disease Study Group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 37 (2001) 1008-1015
20. Pell J.P., Pell A.C., Jeffrey R.R., et al. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures. Diabet Med 21 (2004) 790-792
21. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49 (2007) 1600-1606